title: Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice.
abstract: The severity of antigen-induced arthritis (AIA) is decreased in leptin-deficient ob/ob mice. However, joint inflammation in AIA depends on the immune response, which is impaired in ob/ob mice. In the present study we investigated the effects of leptin deficiency on zymosan-induced arthritis (ZIA), which is independent of adaptive immunity. Arthritis was induced by injection of zymosan into the knee joint. Joint swelling was similar after 6 and 24 hours in ob/ob and control mice. However, it remained elevated in ob/ob animals on day 3 whereas values normalized in controls. Histology revealed similar articular lesions in all animals on day 3, but on days 14 and 21 arthritis tended to be more severe in ob/ob mice. The acute phase response, reflected by circulating levels of IL-6 and serum amyloid A, was also more pronounced in ob/ob mice, although corticosterone was significantly elevated in these animals. Similar results were obtained in leptin receptor-deficient db/db mice. Thus, in contrast to AIA, ZIA is not impaired in leptin-deficient animals. On the contrary, resolution of acute inflammation appears to be delayed in the absence of leptin or leptin signalling, suggesting that chronic leptin deficiency interferes with adequate control of the inflammatory response in ZIA.
authors.affiliation: Division of Rheumatology, University Hospital and Department of Pathology, University of Geneva School of Medicine, Geneva, Switzerland. bernotiene@yahoo.com <bernotiene@yahoo.com>
authors.forename: Eiva
authors.initials: E
authors.lastname: Bernotiene
authors.forename: Gaby
authors.initials: G
authors.lastname: Palmer
authors.forename: Dominique
authors.initials: D
authors.lastname: Talabot-Ayer
authors.forename: Ildiko
authors.initials: I
authors.lastname: Szalay-Quinodoz
authors.forename: Michel L
authors.initials: ML
authors.lastname: Aubert
authors.forename: Cem
authors.initials: C
authors.lastname: Gabay
mesh_terms: D000208:Acute Disease; D000210:Acute-Phase Reaction / Q000097:blood / Q000209:etiology / Q000235:genetics / Q000473:pathology; D000818:Animals; D001169:Arthritis, Experimental / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D003345:Corticosterone / Q000097:blood; D016207:Cytokines / Q000378:metabolism; D004487:Edema / Q000097:blood / Q000209:etiology / Q000235:genetics / Q000473:pathology; D007249:Inflammation / Q000097:blood / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D007719:Knee Joint / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D020738:Leptin / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D012333:RNA, Messenger / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000172:deficiency / Q000502:physiology; D054411:Receptors, Leptin; D012720:Severity of Illness Index; D015054:Zymosan / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D016207:Cytokines; D020738:Leptin; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; C515447:leptin receptor, mouse; D015054:Zymosan; D003345:Corticosterone